[
  {
    "ts": null,
    "headline": "Why Is Alkermes (ALKS) Down 6.6% Since Last Earnings Report?",
    "summary": "Alkermes (ALKS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "url": "https://finnhub.io/api/news?id=8a9472d76f342b45e76743994bd8e566a24bbc72fda771b03a210ce6f8279ce4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741966234,
      "headline": "Why Is Alkermes (ALKS) Down 6.6% Since Last Earnings Report?",
      "id": 133185492,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Alkermes (ALKS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
      "url": "https://finnhub.io/api/news?id=8a9472d76f342b45e76743994bd8e566a24bbc72fda771b03a210ce6f8279ce4"
    }
  },
  {
    "ts": null,
    "headline": "3 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now",
    "summary": "Many investors view the healthcare sector as a safe haven when the stock market is turbulent.  Here are three no-brainer healthcare stocks to buy with $1,000 right now.  AbbVie's product lineup is led by blockbuster drugs targeting autoimmune diseases, with Rinvoq and Skyrizi delivering especially strong sales growth.",
    "url": "https://finnhub.io/api/news?id=1fcb64ba72c5293d17db314666aaa3d41ddd60f3991245113ebc4f76295dfc8e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741945860,
      "headline": "3 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now",
      "id": 133184482,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Many investors view the healthcare sector as a safe haven when the stock market is turbulent.  Here are three no-brainer healthcare stocks to buy with $1,000 right now.  AbbVie's product lineup is led by blockbuster drugs targeting autoimmune diseases, with Rinvoq and Skyrizi delivering especially strong sales growth.",
      "url": "https://finnhub.io/api/news?id=1fcb64ba72c5293d17db314666aaa3d41ddd60f3991245113ebc4f76295dfc8e"
    }
  }
]